SC
INBX icon

SummitTX Capital’s Inhibrx INBX Stock Holding History

SummitTX Capital’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
15,251
-122,570
-89% -$12.3M 0.04% 391
2026
Q1 		$9.27M Buy
137,821
+54,936
+66% +$4.07M 0.29% 74
2025
Q4 		$6.55M Buy
82,885
+28,742
+53% +$1.96M 0.2% 123
2025
Q3 		$1.82M Buy
+54,143
New +$1.33M 0.08% 276

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SummitTX Capital's INBX Position: Q2 2026 in Review

SummitTX Capital reduced its Inhibrx (INBX) stake by 89% in Q2 2026, selling an estimated $12.3M and leaving 15,251 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #391.

SummitTX Capital first reported a position in INBX in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.27M in Q1 2026. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • SummitTX Capital held 15,251 shares of Inhibrx worth $1.45M as of Q2 2026.
  • SummitTX Capital sold 122,570 Inhibrx shares in Q2 2026, an estimated $12.3M.
  • Inhibrx made up 0.04% of SummitTX Capital's portfolio in Q2 2026, its #391 holding.
  • SummitTX Capital first reported a position in Inhibrx in Q3 2025 and has held it in 4 quarters since.
  • SummitTX Capital's Inhibrx position peaked at $9.27M in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.